Arrowhead Research | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Arrowhead Research USD 27.89M 2.3M 2025-03
Incyte USD 325.69M 1.02M 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Ligand Pharmaceuticals USD 18.8M 6.8M 2025-03
Merck USD 2.53B 319M 2025-03
Moderna USD 212M 139M 2025-03
Novartis USD 3.5B 368M 2024-12
Sarepta Therapeutics USD 133.63M 30.24M 2025-03
TG Therapeutics USD 38.96M 3M 2024-12
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12
Xencor USD 17.34M 2.42M 2025-03



Arrowhead Research Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.